Ronapreve Europos Sąjunga - italų - EMA (European Medicines Agency)

ronapreve

roche registration gmbh  - casirivimab, imdevimab - covid-19 virus infection - sieri immuni e immunoglobuline, - ronapreve is indicated for:treatment of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19 (see section 4. prevention of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg (see section 4. the use of ronapreve should take into account information on the activity of ronapreve against viral variants of concern. vedi sezioni 4. 4 e 5.

Gavreto Europos Sąjunga - italų - EMA (European Medicines Agency)

gavreto

roche registration gmbh  - pralsetinib - carcinoma, polmone non a piccole cellule - agenti antineoplastici - gavreto is indicated as monotherapy for the treatment of adult patients with rearranged during transfection (ret) fusion-positive advanced non-small cell lung cancer (nsclc) not previously treated with a ret inhibitor.

Lunsumio Europos Sąjunga - italų - EMA (European Medicines Agency)

lunsumio

roche registration gmbh - mosunetuzumab - linfoma, follicolare - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.

Vabysmo Europos Sąjunga - italų - EMA (European Medicines Agency)

vabysmo

roche registration gmbh - faricimab - wet macular degeneration; macular edema; diabetes complications - oftalmologici - vabysmo is indicated for the treatment of adult patients with:neovascular (wet) age-related macular degeneration (namd),visual impairment due to diabetic macular oedema (dme).

Columvi Europos Sąjunga - italų - EMA (European Medicines Agency)

columvi

roche registration gmbh  - glofitamab - lymphoma, large b-cell, diffuse - agenti antineoplastici - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.

MERON PLUS Italija - italų - Ministero della Salute

meron plus

voco gmbh - cementi provvisori e definitivi da restauro odontoiatrico

MERON Italija - italų - Ministero della Salute

meron

voco gmbh - cementi provvisori e definitivi da restauro odontoiatrico

MERON PLUS AC Italija - italų - Ministero della Salute

meron plus ac

voco gmbh - cementi provvisori e definitivi da restauro odontoiatrico